ORTHO EVRA

ethinyl estradiol / norelgestromin · Janssen Pharmaceuticals (Johnson & Johnson)

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for ORTHO EVRA, covering 2008-10-21 to 2016-07-19. Get the full timeline:

Most recent: Clinical Trial Update: Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.

See pricing